Researchers say they were only trying to “restart” the immune systems of M-S patients with adult stem cells from bone marrow. What they saw was a remarkable remission of the disease. No one’s using the word cure, but no patient with the treatment has had a relapse in nearly seven years. Dr. David Prentice of the Family Research Council.

“I think this is just another brick on the pile of adult stem cells and their ability to effectively treat disease in human patients.”

This is just the latest study that shows how effective adult stem cell research is compared to embryonic stem cell research.

“It’s about time," said Prentice, "that people woke up to the facts, that adult stem cells are the ones that hold real promise to treat patients.”

Richard Doerflinger of the U-S Conference of Catholic Bishops says adult stem cells are now in early trials for treating diseases such as juvenile diabetes, lupus, along with MS.

“The adult stem cells are turning out to be much more useful and more versatile than once thought.”

Which, Doerflinger says, is just the opposite of embryonic stem cells.

“They didn’t expect certain things they didn’t expect that the cells would be so uncontrollable and create tumors when they’re put in animals.”

He says embryonic stem cell scientists are reluctant to give up on their research because of all the money that’s already been invested.